Clinical trial

A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

NCT00144989

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-09-01

PhasePHASE3

Study timeline

Study start (unknown)2002-09-01Date precision: month

Registry last updated2016-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small-Cell-Lung Cancerunresolved

Interventions

Etoposide and cisplatin after chemoradiotherapyDRUG

Irinotecan and cisplatin after chemoradiotherapyDRUG

Sponsors & collaborators

Haruhiko Fukudalead sponsor

Ministry of Health, Labour and Welfare, Japancollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00144989 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.